BonesLabsBlog

BonesLabs Blog

Research Articles & Lab Insights

Updates on our supply, methodology references, and notes from the bench — written by the BonesLabs team for the research community.

Showing 73-90 of 95 posts | page 5/6

No image
Research Article

Follistatin-315

Follistatin-315: A Circulating Activin-Binding Protein Studied in Muscle and Fibrosis Research Research summary. Follistatin is a secreted glycoprotein originally isolated from ovarian follicular fluid as a follicle-stimulating hormone (FSH) inhibitor. It exists in two principal isoforms generated by alternative splicing — Follistatin-315 (FST-315) and Follistatin-288 (FST-288) — together with a 300-residue proteolytic intermediate. FST-315 is […]

BonesLabs
No image
Research Article

Cerebrolysin

Cerebrolysin: A Porcine-Derived Neuropeptide Preparation Research summary. Cerebrolysin is a parenteral neuropeptide preparation manufactured from porcine brain tissue through a controlled enzymatic breakdown process. Unlike single-molecule peptides, Cerebrolysin is a defined mixture of low-molecular-weight peptides and free amino acids derived from CNS tissue, designed to recapitulate the neurotrophic activity of endogenous brain growth factors. The […]

BonesLabs
No image
Research Article

Cagrisema

CagriSema: A Fixed-Dose Cagrilintide–Semaglutide Combination Research summary. CagriSema is a fixed-dose combination of two long-acting peptide hormones developed by Novo Nordisk: cagrilintide (a long-acting amylin analogue) and semaglutide (a long-acting GLP-1 receptor agonist). The combination engages two anatomically and pharmacologically distinct appetite-regulating circuits in a single weekly subcutaneous dose, with the goal of producing greater […]

BonesLabs